Drugs and Supplements

COVID-19 continues to disrupt essential health services in 90% of countries, finds the World Health Organization

Some signs of recovery seen but a concerted effort is required to restore and strengthen health services A 2nd survey by the World Health Organization (WHO) showed that one year into the COVID-19 pandemic, there are still significant disruptions to healthcare services, as reported by 90% of countries indicating they experienced one or more disruptions…

Read More

How do Vaccines Work?


2020 has been an unforgettable year, largely due to COVID-19 which has transformed the world as we know it. The global response has been a massive one, with efforts led by the World Health Organization and its partners. From tracking the pandemic, advising on critical interventions, distributing vital medical supplies to those in need, they…

Read More

Coronavirus: First two patients injected in UK vaccine trial

It might be a little too early to start celebrating our freedom from the current lockdown. However, the first human trial in Europe of a Covid-19 vaccine has begun in Oxford. Initially, two volunteers were injected and were the first out of more than 800 recruited for the study. The study will have half the…

Read More

Ten tips to reduce risk of infections

Ten tips for reducing your risk of infections With the global spread of COVID-19, people are becoming acutely aware of their own health and susceptibility to infections. Maintaining a strong immune system is key to preventing repeated infections. The good news is that simple lifestyle changes can make a significant difference to your ability to…

Read More

First drug to be designed using AI-powered software to start clinical trials for treatment of Obsessive-Compulsive Disorder (OCD)

OCD sufferers may soon have a new hope as a new drug option developed through Artificial Intelligence (AI) will be put through Phase 1 of human clinical trials in March 2020. The drug was designed using Artificial Intelligence (AI) drug discovery technology from UK company Exscientia whilst clinical development will be undertaken by Sumitomo Dainippon…

Read More